Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use

References

• Grand View Research. 2022. https://www.grandviewresearch.com/industry-analysis/skin-lightening-products-market
   Google Scholar
• d‘Ischia M, Wakamatsu K, Cicoira F, Di Mauro E, Garcia-Borron JC, Commo S, Galván I, Ghanem G, Kenzo K, Meredith P. Melanins and melanogenesis: from pigment cells to human health and technological applications. Pigment Cell Melanoma Res. 2015;28(5):520–544.
   PubMed Web of Science ®Google Scholar
• Ramsden CA, Riley PA. Tyrosinase: the four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. Bioorg Med Chem. 2014;22(8):2388–2395.
   PubMed Web of Science ®Google Scholar
• Ismaya WT, Rozeboom HJ, Schurink M, Boeriu CG, Wichers H, Dijkstra BW. Crystallization and preliminary X-ray crystallographic analysis of tyrosinase from the mushroom Agaricus bisporus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011;67(Pt 5):575–578.
   PubMedGoogle Scholar
• Parvez S, Kang M, Chung H-S, Bae H. Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries. Phytother Res. 2007;21(9):805–816.
   PubMed Web of Science ®Google Scholar
• Hridya H, Amrita A, Sankari M, George Priya Doss C, Gopalakrishnan M, Gopalakrishnan C, Siva R. Inhibitory effect of brazilein on tyrosinase and melanin synthesis: Kinetics and in silico approach. Int J Biol Macromol. 2015;81:228–234.
   PubMed Web of Science ®Google Scholar
• Peng Z, Wang G, Zeng Q-H, Li Y, Liu H, Wang JJ, Zhao Y. A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship. Crit Rev Food Sci Nutr. 2022;62(15):4053–4094.
   PubMed Web of Science ®Google Scholar
• Panzella L, Napolitano A. Natural and Bioinspired Phenolic Compounds as Tyrosinase Inhibitors for the Treatment of Skin Hyperpigmentation: Recent Advances. Cosmetics. 2019;6(4):57.
   Google Scholar
• Pillaiyar T, Manickam M, Namasivayam V. Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2017;32(1):403–425.
   PubMed Web of Science ®Google Scholar
• Pillaiyar T, Namasivayam V, Manickam M, Jung S-H. Inhibitors of Melanogenesis: An Updated Review. J Med Chem. 2018;61(17):7395–7418.
   PubMed Web of Science ®Google Scholar
• Lee SY, Baek N, Nam T. Natural, semisynthetic and synthetic tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2016;31(1):1–13.
   PubMed Web of Science ®Google Scholar
• Phasha V, Senabe J, Ndzotoyi P, Okole B, Fouche G, Chuturgoon A. Review on the Use of Kojic Acid—A Skin-Lightening Ingredient. Cosmetics. 2022;9(3):64.
   Google Scholar
• Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, et al. Final report of the safety assessment of kojic acid as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):244S–2473.
   PubMed Web of Science ®Google Scholar
• Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW. Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):274S–2787.
   PubMedGoogle Scholar
• Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. 2020; Cosmeceutical peptides in the framework of sustainable wellness economy. Front Chem. 8:572923.
   PubMed Web of Science ®Google Scholar
• Ledwoń P, Errante F, Papini AM, Rovero P, Latajka R. Peptides as active ingredients: a challenge for cosmeceutical industry. Chem. Biodiversity. 2021;18(2):cbdv.202000833.
   Web of Science ®Google Scholar
• Lupo MP, Cole AL. Cosmeceutical peptides: cosmeceutical peptides. Dermatol Ther. 2007;20(5):343–349.
   PubMed Web of Science ®Google Scholar
• Otvos L, Wade JD. Current challenges in peptide-based drug discovery. Front Chem. 2014;2:62.
   PubMed Web of Science ®Google Scholar
• Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20(1):122–128.
   PubMed Web of Science ®Google Scholar
• Ledwoń P, Papini AM, Rovero P, Latajka R. Peptides and peptidomimetics as inhibitors of enzymes involved in fibrillar collagen degradation. Materials. 2021;14(12):3217.
   PubMed Web of Science ®Google Scholar
• Hariri R, Saeedi M, Akbarzadeh T. Naturally occurring and synthetic peptides: efficient tyrosinase inhibitors. J Pep Sci. 2021;27(7):e3329.
   PubMed Web of Science ®Google Scholar
• Song Y, Chen S, Li L, Zeng Y, Hu X. The hypopigmentation mechanism of tyrosinase inhibitory peptides derived from food proteins: an overview. Molecules. 2022;27(9):2710.
   PubMed Web of Science ®Google Scholar
• Hsiao N-W, Tseng T-S, Lee Y-C, Chen W-C, Lin H-H, Chen Y-R, Wang Y-T, Hsu H-J, Tsai K-C. Serendipitous discovery of short peptides from natural products as tyrosinase inhibitors. J Chem Inf Model. 2014;54(11):3099–3111.
   PubMed Web of Science ®Google Scholar
• Mohan T, Kleinschek KS, Kargl R. Polysaccharide peptide conjugates: chemistry, properties and applications. Carbohydr Polym. 2022;280:118875.
   PubMed Web of Science ®Google Scholar
• Xu L, Xu S, Xiang T, Liu H, Chen L, Jiang B, Yao J, Zhu H, Hu R, Chen Z. Multifunctional building elements for the construction of peptide drug conjugates. Engineered Regeneration. 2022;3(1):92–109.
   Google Scholar
• Balogh B, Ivánczi M, Nizami B, Beke-Somfai T, Mándity IM. ConjuPepDB: a database of peptide–drug conjugates. Nucleic Acids Res. 2021;49(D1):D1102–D1112.
   PubMed Web of Science ®Google Scholar
• CONJUPEPDB. A database of drug-peptide conjugates. 2022. https://conjupepdb.ttk.hu/
   Google Scholar
• He R, Finan B, Mayer JP, DiMarchi RD. Peptide conjugates with small molecules designed to enhance efficacy and safety. Molecules. 2019;24(10):1855.
   PubMed Web of Science ®Google Scholar
• Fu C, Yu L, Miao Y, Liu X, Yu Z, Wei M. Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope? Acta Pharmaceutica Sinica B. 2022;13(2):498–516.
   PubMed Web of Science ®Google Scholar
• Kim H, Choi J, Cho JK, Kim SY, Lee Y-S. Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity. Bioorg Med Chem Lett. 2004;14(11):2843–2846.
   PubMed Web of Science ®Google Scholar
• Noh J-M, Kwak S-Y, Kim D-H, Lee Y-S. Kojic acid–tripeptide amide as a new tyrosinase inhibitor. Biopolymers. 2007;88(2):300–307.
   PubMed Web of Science ®Google Scholar
• Upadhyay A, Chompoo J, Taira N, Fukuta M, Gima S, Tawata S. Solid-phase synthesis of mimosine tetrapeptides and their inhibitory activities on neuraminidase and tyrosinase. J Agric Food Chem. 2011;59(24):12858–12863.
   PubMed Web of Science ®Google Scholar
• Yang J-K, Lee E, Hwang I-J, Yim D, Han J, Lee Y-S, Kim J-H. β-lactoglobulin peptide fragments conjugated with caffeic acid displaying dual activities for tyrosinase inhibition and antioxidant effect. Bioconjug Chem. 2018;29(4):1000–1005.
   PubMed Web of Science ®Google Scholar
• Ebenezer O, Singh-Pillay A, Koorbanally NA, Singh P. Antibacterial evaluation and molecular docking studies of pyrazole–thiosemicarbazones and their pyrazole–thiazolidinone conjugates. Mol Divers. 2021;25(1):191–204.
   PubMed Web of Science ®Google Scholar
• Hassan M, Ghaffari R, Sardari S, Farahani Y, Mohebbi S. Discovery of novel isatin-based thiosemicarbazones: synthesis, antibacterial, antifungal, and antimycobacterial screening. Res Pharm Sci. 2020;15(3):281–290.
   PubMed Web of Science ®Google Scholar
• Sevinçli ZŞ, Duran GN, Özbil M, Karalı N. Synthesis, molecular modeling and antiviral activity of novel 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones. Bioorg Chem. 2020;104:104202.
   PubMed Web of Science ®Google Scholar
• Gu X, Li X, Guan M, Jiang C, Song Q, Sun N, Zou Y, Zhou Q, Chen J, Qiu J. Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells. Bioorg Med Chem Lett. 2020;30(24):127638.
   PubMed Web of Science ®Google Scholar
• Buitrago E, Vuillamy A, Boumendjel A, Yi W, Gellon G, Hardré R, Philouze C, Serratrice G, Jamet H, Réglier M, et al. Exploring the Interaction of N/S Compounds with a Dicopper Center: Tyrosinase Inhibition and Model Studies. Inorg Chem. 2014;53(24):12848–12858.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu J, Zhu X, Yu Y, Cao S. Novel inhibitors of tyrosinase produced by the 4-substitution of TCT. Food Chem. 2017;221:1530–1538.
   PubMed Web of Science ®Google Scholar
• Song S, You A, Chen Z, Zhu G, Wen H, Song H, Yi W. Study on the design, synthesis and structure-activity relationships of new thiosemicarbazone compounds as tyrosinase inhibitors. Eur J Med Chem. 2017;139:815–825.
   PubMed Web of Science ®Google Scholar
• Xie J, Dong H, Yu Y, Cao S. Inhibitory effect of synthetic aromatic heterocycle thiosemicarbazone derivatives on mushroom tyrosinase: Insights from fluorescence, 1 H NMR titration and molecular docking studies. Food Chem. 2016;190:709–716.
   PubMed Web of Science ®Google Scholar
• Dong H, Liu J, Liu X, Yu Y, Cao S. Molecular docking and QSAR analyses of aromatic heterocycle thiosemicarbazone analogues for finding novel tyrosinase inhibitors. Bioorg Chem. 2017;75:106–117.
   PubMed Web of Science ®Google Scholar
• Dong H, Liu J, Liu X, Yu Y, Cao S. Combining molecular docking and QSAR studies for modeling the anti-tyrosinase activity of aromatic heterocycle thiosemicarbazone analogues. J Mol Struct. 2018;1151:353–365.
   Web of Science ®Google Scholar
• Liu J, Li M, Yu Y, Cao S. Novel inhibitors of tyrosinase produced by the 4-substitution of TCT (П). Int J Biol Macromol. 2017;103:1096–1106.
   PubMed Web of Science ®Google Scholar
• Zhu T-H, Cao S-W, Yu Y-Y. Synthesis, characterization and biological evaluation of paeonol thiosemicarbazone analogues as mushroom tyrosinase inhibitors. Int J Biol Macromol. 2013;62:589–595.
   PubMed Web of Science ®Google Scholar
• Hałdys K, Goldeman W, Anger-Góra N, Rossowska J, Latajka R. Monosubstituted Acetophenone Thiosemicarbazones as Potent Inhibitors of Tyrosinase: Synthesis, Inhibitory Studies, and Molecular Docking. Pharmaceuticals. 2021;14(1):74.
   Web of Science ®Google Scholar
• Hałdys K, Goldeman W, Jewgiński M, Wolińska E, Anger-Góra N, Rossowska J, Latajka R. Halogenated aromatic thiosemicarbazones as potent inhibitors of tyrosinase and melanogenesis. Bioorg Chem. 2020;94:103419.
   PubMed Web of Science ®Google Scholar
• Hałdys K, Goldeman W, Jewgiński M, Wolińska E, Anger N, Rossowska J, Latajka R. Inhibitory properties of aromatic thiosemicarbazones on mushroom tyrosinase: Synthesis, kinetic studies, molecular docking and effectiveness in melanogenesis inhibition. Bioorg Chem. 2018;81:577–586.
   PubMed Web of Science ®Google Scholar
• Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J. Am. Chem. Soc. 1963;85(14):2149–2154.
   Web of Science ®Google Scholar
• Carpino LA, Han GY. 9-Fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem. 1972;37(22):3404–3409.
   Web of Science ®Google Scholar
• Bellei B, Pitisci A, Izzo E, Picardo M. Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway, Slominski AT, editor. PLoS One. 2012;7(3):e33021.
   PubMed Web of Science ®Google Scholar
• Gaussian 16, Revision C.01. 2016.
   Google Scholar
• Ismaya WT, Rozeboom HJ, Weijn A, Mes JJ, Fusetti F, Wichers HJ, Dijkstra BW. Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone. Biochemistry. 2011;50(24):5477–5486.
   PubMed Web of Science ®Google Scholar
• Anandakrishnan R, Aguilar B, Onufriev AV. H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 2012;40(Web Server issue):W537–W541.
   PubMed Web of Science ®Google Scholar
• Onufriev A, Anandakrishnan R, Aguilar B. H++, VirginiaTech [Internet]. 2023. http://newbiophysics.cs.vt.edu/H++/
   Google Scholar
• Venkatachalam TK, Pierens GK, Reutens DC. Synthesis, NMR structural characterization and molecular modeling of substituted thiosemicarbazones and semicarbazones using DFT calculations to prove the syn/anti isomer formation: Synthesis and molecular modeling of thiosemicarbazones and semicarbazones. Magn Reson Chem. 2014;52(3):98–105.
   PubMed Web of Science ®Google Scholar
• Fatondji HR, Kpoviessi S, Gbaguidi F, Bero J, Hannaert V, Quetin-Leclercq J, Poupaert J, Moudachirou M, Accrombessi GC. Structure–activity relationship study of thiosemicarbazones on an African trypanosome: Trypanosoma brucei brucei. Med Chem Res. 2013;22(5):2151–2162.
   Web of Science ®Google Scholar
• Thanigaimalai P, Lee K-C, Sharma VK, Roh E, Kim Y, Jung S-H. Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition. Bioorg Med Chem Lett. 2011;21(12):3527–3530.
   PubMed Web of Science ®Google Scholar
• Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, Stäb F, Hearing VJ, Röhm K-H, Kolbe L. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase. J Invest Dermatol. 2018;138(7):1601–1608.
   PubMed Web of Science ®Google Scholar
• Oyama T, Yoshimori A, Ogawa H, Shirai Y, Abe H, Kamiya T, Tanuma S. The structural differences between mushroom and human tyrosinase cleared by investigating the inhibitory activities of stilbenes. J Mol Struct. 2023;1272:134180.
   Web of Science ®Google Scholar
• GraphPad Prism version 8.0.0 for Windows, GraphPad Software. www.graphpad.com
   Google Scholar
• Jackman MP, Hajnal A, Lerch K. Albino mutants of Streptomyces glaucescens tyrosinase. Biochem J. 1991;274(3):707–713.
   PubMedGoogle Scholar
• Chang T-S. Natural melanogenesis inhibitors acting through the down-regulation of tyrosinase activity. Materials. 2012;5(9):1661–1685.
   Web of Science ®Google Scholar
• Lehraiki A, Abbe P, Cerezo M, Rouaud F, Regazzetti C, Chignon-Sicard B, Passeron T, Bertolotto C, Ballotti R, Rocchi S. Inhibition of melanogenesis by the antidiabetic metformin. J Invest Dermatol. 2014;134(10):2589–2597.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. J Mol Biol. 1997;267(3):727–748.
   PubMed Web of Science ®Google Scholar